Concepedia

Avi Ashkenazi

AA

Statistics

Publications

142

Citations

25.4K

H-Index

72

Active since

1984

Affiliations

Molecular Oncology (United States)(Current)

University of California, San Francisco

Gene Therapy Laboratory

Thomas Jefferson University

Genentech

Avi Ashkenazi is an author at Molecular Oncology (United States) specializing in life sciences, cell signaling, and signal transduction.

ORCID

Publications per year

1984–2024

142

Publications

142

Safety and antitumor activity of recombinant soluble Apo2 ligand

Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text

, , +17

Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

Robert Pitti, Scot A. Marsters, Siegfried Ruppert et al. · Journal of Biological Chemistry · 1996 · 1.8K citations · Full text

, , +17

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

James P. Sheridan, Scot A. Marsters, Robert Pitti et al. · Science · 1997 · 1.7K citations

, , +17

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

Robert Pitti, Scot A. Marsters, David A. Lawrence et al. · Nature · 1998 · 773 citations

, , +17

Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors.

E G Peralta, Avi Ashkenazi, John Winslow et al. · The EMBO Journal · 1987 · 765 citations · Full text

, , +15

1–5 of 142